Loading chat...

PA HR892

Resolution

Status

Introduced

5/18/2016

Primary Sponsor

Frank Burns

Click for details

Origin

House of Representatives

2015-2016 Regular Session

AI Summary

Legislative Description

Requesting the Congress of the United States to urge the Food and Drug Administration to reverse its directive allowing OxyContin to be prescribed to children 11 to 16 years of age.

Last Action

Referred to HEALTH

5/18/2016

Committee Referrals

Health5/18/2016

Full Bill Text

No bill text available